Fate Therapeutics, Inc.
FATE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $42 | $61 | $134 |
| Short-Term Investments | $243 | $273 | $375 | $482 |
| Receivables | $4 | $2 | $38 | $9 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $15 | $27 | $9 |
| Total Curr. Assets | $292 | $332 | $502 | $633 |
| Property Plant & Equip (Net) | $111 | $159 | $66 | $162 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $28 | $1 | $5 | $101 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $15 | $132 | $25 |
| Total NC Assets | $149 | $175 | $203 | $288 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $441 | $506 | $706 | $921 |
| Liabilities | – | – | – | – |
| Payables | $9 | $5 | $8 | $9 |
| Short-Term Debt | $7 | $6 | $6 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $42 | $21 |
| Other Curr. Liab. | $21 | $28 | $58 | $46 |
| Total Curr. Liab. | $39 | $39 | $114 | $81 |
| LT Debt | $78 | $97 | $104 | $109 |
| Deferred Rev, NC | $0 | $0 | $0 | $27 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $1 | $4 | $25 |
| Total NC Liab. | $83 | $99 | $108 | $161 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $85 | $104 | $109 | $115 |
| Total Liabilities | $122 | $138 | $222 | $243 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,398 | -$1,212 | -$1,051 | -$769 |
| AOCI | $0 | $0 | -$2 | -$1 |
| Other Equity | $1,716 | $1,580 | $1,536 | $1,449 |
| Total Equity | $319 | $368 | $484 | $679 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $441 | $506 | $706 | $921 |
| Net Debt | $49 | $62 | $48 | -$19 |